Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. KEY INTERMEDIATE SUPPLY AGREEMENTKey Intermediate Supply Agreement • March 16th, 2018 • Nabriva Therapeutics PLC • Pharmaceutical preparations
Contract Type FiledMarch 16th, 2018 Company IndustryTHIS KEY INTERMEDIATE SUPPLY AGREEMENT (this “Agreement”) is made as of this 28th day of August 2017 (“Effective Date”), by and among NABRIVA THERAPEUTICS IRELAND DAC (“NABRIVA”), and SEL BIOCHEM XINJIANG CO., LTD (“SEL”) and FOUNTAIN INTERNATIONAL DEVELOPMENT HOLDING LIMITED (“FOUNTAIN”). NABRIVA, SEL, and FOUNTAIN are hereinafter collectively referred to as the “Parties.”